Sign up
Log in
Why Clarity Pharmaceuticals, GQG Partners, Light & Wonder, and QBE shares are dropping today
Share
Listen to the news

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.2% to 8,816.3 points.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

Clarity Pharmaceuticals Ltd (ASX: CU6)

The Clarity Pharmaceuticals share price is down 10% to $3.93. This may have been driven by concerns over the release of updates from other radiopharmaceuticals companies which warned of increased pricing pressures in the PSMA imaging market.

GQG Partners Inc (ASX: GQG)

The GQG Partners share price is down 14% to $1.73. This follows the release of the fund manager's latest funds under management (FUM) update, which revealed a sizeable monthly outflow. This is being driven by the company's peculiar decision to avoid in form areas of the market because of valuation concerns and fears a pullback could cause an underperformance. But with its funds underperforming because of this decision and management warning that this could lead to greater fund outflows, the market is unsurprisingly hitting the sell button today.

Light & Wonder Inc. (ASX: LNW)

The Light & Wonder share price is down 9% to $121.35. This follows a selloff of the gaming technology company's Nasdaq listed shares overnight. It seems that some investors were disappointed with the company's second quarter update. And while Bell Potter wasn't overly impressed, it remains bullish and has retained its buy rating with a trimmed price target of $178.00 (from $194.00). It said: "We put the disappointing 2Q25 AEBITDA guidance downgrade down to tariff related issues and note that macroeconomic risks remain. We point to robust install base growth in 2Q25 and strong game performance as evidence that the thesis of market share gains in the lucrative premium leased segment remains intact. We see the November 2025 ASX sole listing plan as a key catalyst for a re-rate in the stock but note execution risks exist."

QBE Insurance Group Ltd (ASX: QBE)

The QBE Insurance share price is down almost 7% to $21.85. Investors have been selling this insurance giant's shares following the release of its half year results. QBE reported gross written premiums (GWP) of US$13.82 billion and a net profit after tax of US$802 million. Bell Potter was looking for GWP US$13,707 million and net profit after tax of US$838 million. Its interim dividend of 31 cents per share was also well short of the broker's estimate of 39.6 cents per share.

The post Why Clarity Pharmaceuticals, GQG Partners, Light & Wonder, and QBE shares are dropping today appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has positions in Gqg Partners. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder. The Motley Fool Australia has recommended Gqg Partners and Light & Wonder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.